Selection of first in vitro fertilization cycle stimulation protocol for good prognosis patients gonadotropin releasing hormone antagonist versus agonist protocols

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 56, Issue 1-2, 2011, Pages 12-16

  Johnston Macananny, Erika B ^a,b   Diluigi, Andrea J ^a,b   Engmann, Lawrence L ^a,b   Maier, Donald B ^a,b   Benadiva, Claudio A ^a,b   Nulsen, John C ^a,b  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Gnrh agonist; Gnrh antagonist; Hyperresponder; In vitro fertilization; Ovarian hyperstimulation syndrome; Protocol

Indexed keywords

FOLLITROPIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST;

ADULT; ARTICLE; BIRTH RATE; FEMALE; FERTILIZATION IN VITRO; FOLLITROPIN BLOOD LEVEL; HUMAN; LIVE BIRTH; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; NIDATION; OUTCOME ASSESSMENT; PREGNANCY RATE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT RESPONSE; UNIVERSITY HOSPITAL;

ADULT; CHORIONIC GONADOTROPIN; CRYOPRESERVATION; EMBRYO, MAMMALIAN; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; HUMANS; MENOTROPINS; OVARIAN FOLLICLE; PREGNANCY; PREGNANCY RATE; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 79951571029     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Al-Inany HG, Aboulghar M: GnRH antagonist in assisted reproduction: A Cochrane review. Hum Reprod 2002;17:874-885
2. Al-Inany HG, Abou-Setta AM, Aboulghar M: title typecontributorGonadotropinreleasing hormone antagonists for assisted conception/title. Cochrane Database Syst Rev 2006;3:CD001750
3. Huirne JA, Romberg R, Lambalk CB: Are GnRH antagonists comparable to agonists for use in IVF? Hum Reprod 2007; 22:2805-2813
4. Kolibianakis EM, Collins J, Tarlatzis BC, et al: Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Hum Reprod Update 2006;12:651-671
5. Fasouliotis SJ, Laufer N, Sabbagh-Ehrlich S, et al: Gonadotropinreleasing hormone (GnRH)-antagonist versus GnRH-agonist in ovarian stimulation of poor responders undergoing IVF. J Assist Reprod Genet 2003;20:455-460
6. Cheung LP, Lam PM, Lok IH, et al: GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: A randomized controlled trial. Hum Reprod 2005;20: 616-621
7. Schmidt DW, Bremner T, Orris JJ, et al: A randomized prospective study of microdose leuprolide versus ganirelix in in vitro fertilization cycles for poor responders. Fertil Steril 2005;83:1568-1571
8. Marci R, Caserta D, Dolo V, et al: GnRH antagonist in IVF poor-responder patients: Results of a randomized trial. Reprod Biomed Online 2005;11:189-193
9. Pabuccu R, Onalan G, Kaya C: GnRH agonist and antagonist protocols for stage I-II endometriosis and endometrioma in in vitro fertilization/intracytoplasmic sperm injection cycles. Fertil Steril 2007;88:832-839
10. Ricciarelli E, Sanchez M, Martinez M, et al: Impact of the gonadotropin-releasing hormone antagonist in oocyte donation cycles. Fertil Steril 2003;79:1461-1463
11. Prapas N, Prapas Y, Panagiotidis Y, et al: GnRH agonist versus GnRH antagonist in oocyte donation cycles: A prospective randomized study. Hum Reprod 2005;20:1516-1520
12. Barad DH, Weghofer A, Gleicher N: Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function. Obstet Gynecol 2007;109:1404-1410
13. Arslan M, Bocca S, Mirkin S, et al: Controlled ovarian hyperstimulation protocols for in vitro fertilization: Two decades of experience after the birth of Elizabeth Carr. Fertil Steril 2005;84:555-569
14. Orvieto R, Rabinson J, Meltzer S, et al: GnRH agonist versus GnRH antagonist in ovarian stimulation: Is the emperorv naked? Clin Exp Obstet Gynecol 2006;33:197-199
15. Barmat LI, Chantilis SJ, Hurst BS, et al: A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization. Fertil Steril 2005;83:321-330
16. Check ML, Check JH, Choel JK, et al: Effect of antagonists vs agonists on in vitro fertilization outcome. Clin Exp Obstet Gynecol 2004;31:257-259
17. Wilcox J, Potter D, Moore M, et al: Prospective, randomized trial comparing cetrorelix acetate and ganirelix acetate in a programmed, flexible protocol for premature luteinizing hormone surge prevention in assisted reproductive technologies. Fertil Steril 2005;84:108-117
18. Shapiro DB: GnRH antagonists in normal-responder patients. Fertil Steril (Suppl 1) 2003;80:S8-S15
19. Engmann L, Siano L, Schmidt D, et al: GnRH agonist to induce oocyte maturation during IVF in patients at high risk of OHSS. Reprod Biomed Online 2006;13:639-644
20. DiLuigi AJ, Engmann L, Siano L, et al: Leuprolide acetate trigger effectively prevents ovarian hyperstimulation syndrome (OHSS) without compromising clinical outcomes in patients with serum estradiol (E2) >4000 pg/mL in IVF cycles. Fertil Steril (Suppl 1) 2007;88:S118
21. Ragni G, Vegetti W, Riccaboni A, et al: Comparison of GnRH agonists and antagonist in assisted reproduction cycles of patients at high risk of ovarian hyperstimulation syndrome. Hum Reprod 2005;20:2421-2425
22. Hohmann FP, Macklon NS, Fauser BC: A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol. J Clin Endo Metab 2003;88:166-173